Press releases & articles
This section includes 'reprints' of recently published articles and documents featuring Harten Group. (You will need a PDF reader such as Adobe Acrobat to view some these documents.)
Creating a winning team
The relationship betweeen medics and marketers is crucial in driving pharma companies and their brands forward, but it often faces competing challenges; these can be overcome using simple techniques. Article br Dr Malcolm Barratt-Johnson published in Pharmaceutical Marketing Europe, September 2011
Inspections - How to turn yours into a positive experience
With Inspections becoming increasingly frequent and more rigorous across Europe, how can you ensure that if you have one it is informative, constructive and helpful rather than negative for the company's credibility and image?. Feature published in PIPELINE, March 2011
Project enhancement
Clever deployment of a skilled interim manager can bring concentrated focus to a task and job satisfaction to the worker. Feature published in Pharmaceutical Marketing Europe, November/December 2010
The value of working with a skilled partner
Vernon Harten-Ash explains how Harten Group can help by providing multi-disciplinary consultancy teams, individual specialist interim managers, or finding someone for a 'difficult to fill' permanent role. Feature published in Business Weekly, September 2010
Gaining a fuller picture: Careful observation of people's behaviours in their own environments can provide truer insights
Karen Lenoir of ParagonRx International discusses how ethnography - where researchers observe people doing things - is making a significant impact on new product development and marketing. Feature published in Pharmaceutical Marketing Europe, May 2010
Genomics, personalised medicine and clinical trials
Abel Ureta-Vidal discusses how genomics can impact on management of clinical trials. Feature published in Phamrmaceutical Consultation Expertise, May 2010
'Crisis? What Crisis?' The 2009/2010 Harten Group Annual Industry Survey
Our eighth annual industry survey looks at how events turned out compared to the gloomy outlook at the time of the previous year's survey, conducted in the immediate aftermath of the financial meltdown and the start of the global recession. Was the year as bad as they feared or were there any unexpected highlights? It also takes a cautious look at what 2010 might hold. Feature published in CR Focus, March 2010
How Will Personalised Medicine Have an Impact on Clinical Trials?
Abel Ureta-Vidal discusses how genomics can have an impact on management of clinical trials, and what this could mean for the pharmaceutical industry and the patient. Feature published in CR Focus, November 2009
Drug Safety - Does it Work?
People working in Pharmacovigilance strive to implement the regulations - but can they be confident that the output of their activity is translated into more informative and useful product information for the prescriber or patients? Article published in Pipeline, November 2009
Flexible Resourcing: the perfect solution in challenging times
The global financial crisis, increasing cost pressures and the constant need to reduce overheads means there's never been a better time to harness the benefits of using interim expertise. Text of an article published in Pharmafocus, August 2009
Interim Measure
Discussion of how Interim Management is enjoying significant growth as companies look for more flexible outsourcing solutions. Text of an article published in Pharmaceutical Marketing, July 2009
Q10 Talking Heads
Vernon Harten-Ash talks about finding the right people and the globally-renowned pharma and biotech cluster in the East of England. Published in Business Weekly, June 2009
How interim providers can bring new international benefits to biotechs
Tim Ewbank explains how interim providers can help access international expertise. Published in Business Weekly, June 2009
What a Difference a Year Makes! The 2008/9 Harten Group Survey
How has the economic turbulence of the past 12 months impacted on the pharma and biotech sectors? Harten Group's seventh annual industry survey takes a look at the facts behind the headlines. Published in CR Focus, April 2009
SPECIAL FEATURE: The Role Of The Consultant Pharmaceutical Physician
Lesley Crosland discusses how the role has changed over the past ten years. Text of article published in Pharmaceutical Physician, November 2008
Rapid Access to Specialist Skills
Tim Ewbank discusses 'The Hows and Whys of Interim Management' in this article, published in CR Focus, October 2008
Working in vaccines, a primer
Considering a career in vaccines? Novartis Vaccines & Diagnostics medical director provides a run-down of the top issues in this exciting field. Text of article published in Pharmafocus, October 2008
GCP: It's never too early to start
Vernon Harten-Ash and Val Lyness offer Biotech start-ups tips to achieving trial success in addition to maintaining GCP compliance. Text of article published in GCPj, June 2008